Delivery Order SPE2DB24D2010-SPE2DB25FABGZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,256.00 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,247.47. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which supplies pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.26 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-unit count). This firm fixed price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $19,348.64 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count) on September 15, 2025, with completion due by September 16, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract valued at $3,059.76. The order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count packages) valued at $2,931.72. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on August 29, 2025, with completion scheduled for September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and serves the federal government's pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract is valued at $4,627.98 under a firm fixed-price arrangement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABGZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,615.97 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's contract portfolio demonstrates consistent capability in competitively awarded federal procurements involving pharmaceutical products across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.6k | 9/19/25 |